サワイグループホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/06/21 | 3,557 | 3,610 | 3,557 | 3,601 | +58 | +1.6% | 249,200 |
| 2023/06/20 | 3,498 | 3,545 | 3,491 | 3,543 | +50 | +1.4% | 265,200 |
| 2023/06/19 | 3,490 | 3,513 | 3,463 | 3,493 | +52 | +1.5% | 213,200 |
| 2023/06/16 | 3,403 | 3,446 | 3,385 | 3,441 | +42 | +1.2% | 313,200 |
| 2023/06/15 | 3,373 | 3,413 | 3,369 | 3,399 | -8 | -0.2% | 221,600 |
| 2023/06/14 | 3,375 | 3,407 | 3,338 | 3,407 | +67 | +2% | 246,400 |
| 2023/06/13 | 3,380 | 3,388 | 3,333 | 3,340 | -26 | -0.8% | 283,100 |
| 2023/06/12 | 3,378 | 3,389 | 3,347 | 3,366 | +31 | +0.9% | 202,200 |
| 2023/06/09 | 3,305 | 3,342 | 3,305 | 3,335 | +46 | +1.4% | 208,300 |
| 2023/06/08 | 3,330 | 3,338 | 3,272 | 3,289 | -29 | -0.9% | 254,100 |
| 2023/06/07 | 3,320 | 3,361 | 3,288 | 3,318 | +14 | +0.4% | 371,800 |
| 2023/06/06 | 3,320 | 3,325 | 3,270 | 3,304 | -35 | -1% | 226,800 |
| 2023/06/05 | 3,375 | 3,379 | 3,338 | 3,339 | +34 | +1% | 194,100 |
| 2023/06/02 | 3,270 | 3,310 | 3,260 | 3,305 | +45 | +1.4% | 222,000 |
| 2023/06/01 | 3,310 | 3,340 | 3,255 | 3,260 | -40 | -1.2% | 238,500 |
| 2023/05/31 | 3,325 | 3,350 | 3,295 | 3,300 | -85 | -2.5% | 519,400 |
| 2023/05/30 | 3,505 | 3,505 | 3,375 | 3,385 | -140 | -4% | 327,900 |
| 2023/05/29 | 3,555 | 3,555 | 3,505 | 3,525 | -15 | -0.4% | 184,800 |
| 2023/05/26 | 3,570 | 3,585 | 3,530 | 3,540 | -80 | -2.2% | 243,800 |
| 2023/05/25 | 3,675 | 3,720 | 3,610 | 3,620 | -75 | -2% | 197,200 |
| 2023/05/24 | 3,735 | 3,735 | 3,685 | 3,695 | -20 | -0.5% | 110,400 |
| 2023/05/23 | 3,725 | 3,745 | 3,675 | 3,715 | -10 | -0.3% | 212,900 |
| 2023/05/22 | 3,690 | 3,730 | 3,680 | 3,725 | +50 | +1.4% | 92,700 |
| 2023/05/19 | 3,690 | 3,700 | 3,655 | 3,675 | -40 | -1.1% | 214,000 |
| 2023/05/18 | 3,795 | 3,795 | 3,675 | 3,715 | -85 | -2.2% | 242,600 |
| 2023/05/17 | 3,790 | 3,840 | 3,785 | 3,800 | +25 | +0.7% | 148,600 |
| 2023/05/16 | 3,730 | 3,775 | 3,715 | 3,775 | +70 | +1.9% | 126,500 |
| 2023/05/15 | 3,705 | 3,710 | 3,640 | 3,705 | +5 | +0.1% | 232,700 |
| 2023/05/12 | 3,770 | 3,785 | 3,660 | 3,700 | -140 | -3.6% | 414,600 |
| 2023/05/11 | 3,920 | 3,920 | 3,830 | 3,840 | -100 | -2.5% | 109,000 |
| 2023/05/10 | 3,950 | 3,955 | 3,920 | 3,940 | -25 | -0.6% | 77,400 |
| 2023/05/09 | 3,970 | 3,985 | 3,945 | 3,965 | +25 | +0.6% | 90,700 |
| 2023/05/08 | 3,935 | 3,975 | 3,925 | 3,940 | +15 | +0.4% | 84,000 |
| 2023/05/02 | 3,950 | 3,955 | 3,900 | 3,925 | -5 | -0.1% | 71,500 |
| 2023/05/01 | 3,905 | 3,940 | 3,885 | 3,930 | +5 | +0.1% | 133,000 |
| 2023/04/28 | 3,885 | 3,940 | 3,885 | 3,925 | +75 | +1.9% | 177,100 |
| 2023/04/27 | 3,840 | 3,855 | 3,810 | 3,850 | +15 | +0.4% | 98,500 |
| 2023/04/26 | 3,900 | 3,905 | 3,830 | 3,835 | -60 | -1.5% | 141,900 |
| 2023/04/25 | 3,880 | 3,905 | 3,860 | 3,895 | +20 | +0.5% | 99,400 |
| 2023/04/24 | 3,865 | 3,890 | 3,860 | 3,875 | +20 | +0.5% | 71,200 |
| 2023/04/21 | 3,820 | 3,865 | 3,805 | 3,855 | +25 | +0.7% | 84,200 |
| 2023/04/20 | 3,850 | 3,850 | 3,820 | 3,830 | -15 | -0.4% | 65,100 |
| 2023/04/19 | 3,830 | 3,855 | 3,820 | 3,845 | ±0 | ±0% | 91,500 |
| 2023/04/18 | 3,860 | 3,865 | 3,835 | 3,845 | -5 | -0.1% | 83,900 |
| 2023/04/17 | 3,865 | 3,880 | 3,840 | 3,850 | -15 | -0.4% | 84,700 |
| 2023/04/14 | 3,855 | 3,875 | 3,845 | 3,865 | +35 | +0.9% | 139,800 |
| 2023/04/13 | 3,810 | 3,830 | 3,795 | 3,830 | +20 | +0.5% | 76,300 |
| 2023/04/12 | 3,825 | 3,830 | 3,775 | 3,810 | +15 | +0.4% | 98,200 |
| 2023/04/11 | 3,780 | 3,810 | 3,770 | 3,795 | +45 | +1.2% | 128,800 |
| 2023/04/10 | 3,735 | 3,755 | 3,730 | 3,750 | +40 | +1.1% | 95,700 |
501～
550
件表示中 / 1044件
類似銘柄と比較する
現在ご覧いただいている「サワイＧＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サワイＧＨＤ | 180,300円 | +5.9% | +684.6% | 3.05% | 11.97倍 | 1.20倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| ツムラ | 350,800円 | +3.8% | -19.9% | 3.88% | 11.39倍 | 0.87倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 日本新薬 | 311,800円 | +8.0% | -15.3% | 3.98% | 8.75倍 | 0.85倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ペプチド | 152,700円 | +5.0% | +1.5% | 0.00% | 13.06倍 | 3.48倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| キッセイ薬 | 396,000円 | +3.6% | +6.1% | 3.03% | 13.34倍 | 0.79倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム
